Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: AgAuUSA who wrote (8365)	3/4/1998 1:25:00 PM
From: Howard Frederick	Respond to of 14328

I agree with what you are saying about Buffett. My diatribe wasn't meant to be a discussion of all, or even most, of what he looks at. It was more of an attempt to show why TRIBY's stock price isn't higher at present. For me, TRIBY's stock price will be driven by sales/earnings, especially sales, over the next year. I expect earnings to be lumpy, and possibly even negative for one or more quarters in the next year. I think they may incur heavy costs associated with moving/opening new production facilities, and they still may incur costs associated with consolidating last year's acquisitions. The flags for me over the next year are: 1) Sales are steadily increasing, 2) They aren't incurring too much debt or dilution from additional stock offerings, and 3) Margins are healthy. Incidentally, I have a different view on stock repurchases. For TRIBY I don't think they would be a good idea. I think they could better use the funds to grow sales/production capacity. IMO, stock repurchases are for a much more mature company. Howard Don't be insulted if I don't return posts. I don't have the free time to post as much as I would like, and barely have the time to read posts. FWIW, I enjoy this thread very much.